BofA Securities Downgrades Amn Healthcare to Underperform, PT Lowered to $18

BofA Securities Downgrades Amn Healthcare to Underperform, PT Lowered to $18

In a significant move, BofA Securities has downgraded AMN Healthcare Services Inc (AMN) to "Underperform" and lowered its price target to $18, as reported by MarketBeat [1]. The decision comes amidst a wave of analyst downgrades and selling pressure on the stock.

Northern Trust Corp recently reduced its stake in AMN by 29.4%, selling 188,270 shares to end the first quarter with 452,836 shares valued at approximately $11.08 million [1]. This reduction follows a series of analyst downgrades from BMO Capital Markets, UBS Group, and JMP Securities, which have all cut their price targets for AMN, with consensus estimates now ranging from $22.00 to $25.50 [1].

AMN Healthcare Services reported $0.30 earnings per share for the last quarter, exceeding analysts’ estimates of $0.17, despite a year-over-year revenue decline of 11.1% [1]. Despite this positive earnings surprise, the stock has faced significant selling pressure, with institutional investors owning 99.23% of the company's stock [1].

Other large investors have also made notable changes to their positions in AMN Healthcare Services. Newtyn Management LLC acquired a new position worth $28,417,000 during the fourth quarter, while Charles Schwab Investment Management Inc. raised its position by 1.9% in the first quarter, now owning 904,275 shares valued at $22,119,000 [1]. Reinhart Partners LLC grew its holdings by 44.4%, and New South Capital Management Inc. increased its position by 13.0%, while Two Sigma Investments LP grew its position by 228.8% during the fourth quarter [1].

Shares of AMN traded down $1.08 during midday trading on Wednesday, hitting $19.76, with a fifty-day moving average price of $19.79 and a 200-day moving average price of $21.23 [1]. The company has a one-year low of $14.86 and a one-year high of $48.49, with a market capitalization of $757.01 million, a price-to-earnings ratio of -2.55, and a beta of 0.12 [1].

The downgrade by BofA Securities adds to the existing negative sentiment surrounding AMN Healthcare Services, with analysts from various firms reducing their price targets and changing their ratings. As the company continues to navigate the challenges of a declining revenue and the impact of analyst downgrades, investors will be closely watching the stock's performance and any potential catalysts for a turnaround.

[1] https://www.marketbeat.com/instant-alerts/filing-northern-trust-corp-sells-188270-shares-of-amn-healthcare-services-inc-amn-2025-09-05/